The hiccup reportedly won’t ruin the pharmaceutical company’s ambitious plans to produce 20 million doses this month, and even more shots specifically for US citizens in early 2021.
Moderna Inc. had to dispose of 400,000 doses of its experimental coronavirus inoculation due to a filtration issue that arose during the final stages of manufacturing, Bloomberg reported, citing Moncef Slaoui, Operation Warp Speed’s chief scientific adviser.
Continue reading https://sptnkne.ws/EGfE